ICU SeaStar Medical Holding Corporation
3.720USD+16.61%Mkt Cap: 19.57M $P/E: —1d ago
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
SeaStar Medical Holding Corp (ICU) (Q2 2026) Earnings Call Highlights: Qualimmune Revenue ... Pediatric adoption doubles to 20 top children's hospitals, while Neutralize-AKI trial enrollment accelerates toward late-2027 PMA submission. | ||
 SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript Revenue surged 82% year-over-year as hospital adoption doubled to 20 sites. | ||